Built to Adapt: The Marketing Teams That Will Thrive in 2026
By Matt Wilkinson
Five Questions That Separate Customer Insight From Wishful Thinking
By Jasmine Gruia-Gray
2026 Has Arrived. Here Are the Six Shifts That Will Define It
By Matt Wilkinson
The Janus Threshold: When to Deploy AI in Product Development Research
By Jasmine Gruia-Gray
Daedalus' Blueprint: Why Your Product Requirements Document Prevents You From Building a Labyrinth
By Jasmine Gruia-Gray
The AI Maturity Myth
By Matt Wilkinson
The Argonaut's Guide to 12-18 Month Product Roadmaps
By Jasmine Gruia-Gray
AI Can Also Stand for Accelerated Insight
By Matt Wilkinson
Meetings Are Where Roadmaps Go To Die: The Three-Element Meeting Filter
By Jasmine Gruia-Gray
ELRIG Drug Discovery 2025: 68% AI Optimistic, Only 7% Winning
By Matt Wilkinson
Life Science Commercial Blind Spots
By Jasmine Gruia-Gray
AI Isn't the Risk. Waiting Is.
By Matt Wilkinson
Icarus Trap to Launch Ready
By Jasmine Gruia-Gray
While You Ignore AI, Your Competitors Are Training for It
By Matt Wilkinson
Taming the Hydra: Managing Scope Creep in Life Sciences Research Tools
By Jasmine Gruia-Gray